Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D

Garry R. Barton; Jo Hodgekins; Miranda Mugford; Peter B. Jones; Tim Croudace; David Fowler

doi:10.1192/bjp.bp.108.057380

Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D

Garry R. Barton (Lead / Corresponding author)
, Jo Hodgekins
, Miranda Mugford
, Peter B. Jones
, Tim Croudace
, David Fowler

Research output: Contribution to journal › Article › peer-review

38 Citations (Scopus)

Abstract

The UK National Institute for Health and Clinical Excellence (NICE) has recommended that cost-effectiveness analysis includes the EQ-5D; however, this is often not implemented in the area of mental health.

Original language	English
Pages (from-to)	170-177
Number of pages	8
Journal	British Journal of Psychiatry
Volume	195
Issue number	2
DOIs	https://doi.org/10.1192/bjp.bp.108.057380
Publication status	Published - Aug 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Psychiatry and Mental health

Access to Document

10.1192/bjp.bp.108.057380

Cite this

@article{8eb4391c6e22414490c4d3ee7499a44a,

title = "Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D",

abstract = "The UK National Institute for Health and Clinical Excellence (NICE) has recommended that cost-effectiveness analysis includes the EQ-5D; however, this is often not implemented in the area of mental health.",

keywords = "Psychiatry and Mental health",

author = "Barton, \{Garry R.\} and Jo Hodgekins and Miranda Mugford and Jones, \{Peter B.\} and Tim Croudace and David Fowler",

note = "M1 - Article",

year = "2009",

month = aug,

doi = "10.1192/bjp.bp.108.057380",

language = "English",

volume = "195",

pages = "170--177",

journal = "British Journal of Psychiatry",

issn = "1472-1465",

publisher = "Cambridge University Press",

number = "2",

}

TY - JOUR

T1 - Measuring the benefits of treatment for psychosis

T2 - validity and responsiveness of the EQ-5D

AU - Barton, Garry R.

AU - Hodgekins, Jo

AU - Mugford, Miranda

AU - Jones, Peter B.

AU - Croudace, Tim

AU - Fowler, David

N1 - M1 - Article

PY - 2009/8

Y1 - 2009/8

N2 - The UK National Institute for Health and Clinical Excellence (NICE) has recommended that cost-effectiveness analysis includes the EQ-5D; however, this is often not implemented in the area of mental health.

AB - The UK National Institute for Health and Clinical Excellence (NICE) has recommended that cost-effectiveness analysis includes the EQ-5D; however, this is often not implemented in the area of mental health.

KW - Psychiatry and Mental health

UR - https://www.scopus.com/pages/publications/68549083559

U2 - 10.1192/bjp.bp.108.057380

DO - 10.1192/bjp.bp.108.057380

M3 - Article

C2 - 19648552

SN - 1472-1465

VL - 195

SP - 170

EP - 177

JO - British Journal of Psychiatry

JF - British Journal of Psychiatry

IS - 2

ER -

Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this